Regulations.gov document
BIO Feedback on FDA Guidance During COVID19 Pandemic
Other · FDA-2020-D-1057 · posted Apr 16, 2020
Key facts
| Document ID | FDA-2020-D-1057-0006 |
|---|---|
| Title | BIO Feedback on FDA Guidance During COVID19 Pandemic |
| Document type | Other |
| Subtype | General Correspondence |
| Agency | FDA |
| Docket | FDA-2020-D-1057 |
| Posted | Apr 16, 2020 |
| Comment period opens | Apr 16, 2020 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: